2-(1,3-dioxoisoindol-2-yl)acetaldehyde

We are 2-(1,3-dioxoisoindol-2-yl)acetaldehyde CAS:2913-97-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-(1,3-dioxoisoindol-2-yl)acetaldehyde
CAS.NO:2913-97-5
Synonyms:2-(1,3-dioxoisoindol-2-yl)acetaldehyde
N-Phthalylaminoacetaldehyde
Phthalimidoacetaldehyde
(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-ACETALDEHYDE
Phthalylglycine aldehyde
1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetaldehyde
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 324.3±25.0 °C at 760 mmHg
Melting Point 116-118ºC
Molecular Formula C10H7NO3
Molecular Weight 189.167
Flash Point 151.5±15.5 °C
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rucaparib.

2-(1,3-dioxoisoindol-2-yl)acetaldehyde


Related News: Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).2,2,2-Trifluoroethylamine CAS:753-90-2 It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.591-18-4 Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.(Z)-2-(2-AMINOTHIAZOL-4-YL)-2-ACETYLOXYIMINOACETIC ACID CAS:110130-88-6 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.”Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.

Related Products
Product Name
2-bromo-4-cyanophenol View Details
4-(dibiphenyl-4-ylamino)phenylboronic acid View Details
Bis-TBDMS-trans-calcipotriol View Details
Pyrrolo[2,3-d]pyrimidin-4-ol manufacturer Goserelin acetate manufacturer Adenosine-5′-diphosphate disodium salt manufacturer 4-Guanidinobenzoic acid hydrochloride manufacturer 1,2-Bis(triethoxysilyl)ethane manufacturer